A system to analyze proteins in single cells more effectively
A Nanofluidic/Microfluidic System for Enhanced Low-Input and Single-Cell Proteomics
This study is working on a new way to look at proteins in tiny amounts and in individual cells, which could help us understand how proteins change when diseases occur, leading to better tests and treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fluidispec LLC NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11008589 on NIH RePORTER |
What this research studies
This research focuses on developing a novel microfluidic and nanofluidic system designed to enhance the analysis of proteins at low input levels and in single cells. By improving the methods for preparing and analyzing biological samples, the research aims to provide a clearer understanding of how proteins behave and change in response to diseases. This could lead to better diagnostic tools and more effective treatments by capturing the complexity of cellular functions and their alterations during disease progression.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diseases that involve significant changes in protein expression or modification.
Not a fit: Patients with conditions unrelated to protein dysfunction or those who do not have a need for advanced proteomic analysis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in diagnosing and treating diseases by providing deeper insights into protein behavior at the cellular level.
How similar studies have performed: Previous research has shown promise in using microfluidic technologies for single-cell analysis, indicating that this approach could yield significant advancements in the field.
Where this research is happening
Philadelphia, United States
- Fluidispec LLC — Philadelphia, United States (Active)
Researchers
- Principal investigator: Timperman, Aaron T — Fluidispec LLC
- Study coordinator: Timperman, Aaron T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.